357 related articles for article (PubMed ID: 25712643)
1. Current scenario in inflammatory bowel disease: drug development prospects.
Chandel S; Prakash A; Medhi B
Pharmacol Rep; 2015 Apr; 67(2):224-9. PubMed ID: 25712643
[TBL] [Abstract][Full Text] [Related]
2. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
3. Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease.
Bhat MA; Usman I; Dhaneshwar S
Curr Rev Clin Exp Pharmacol; 2024; 19(3):234-249. PubMed ID: 37859409
[TBL] [Abstract][Full Text] [Related]
4. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
Dharmani P; Chadee K
Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
[TBL] [Abstract][Full Text] [Related]
5. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
6. Current pharmacotherapy for inflammatory bowel disease.
McKaig BC; Stack WA
Expert Opin Pharmacother; 1999 Nov; 1(1):3-14. PubMed ID: 11249561
[TBL] [Abstract][Full Text] [Related]
7. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
8. [Polyphenols in the treatment of inflammatory bowel diseases].
Chojnacka K; Laskowska J
Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
[TBL] [Abstract][Full Text] [Related]
9. A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease.
Aardoom MA; Veereman G; de Ridder L
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126015
[TBL] [Abstract][Full Text] [Related]
10. Treatment of inflammatory bowel disease (IBD).
Pithadia AB; Jain S
Pharmacol Rep; 2011; 63(3):629-42. PubMed ID: 21857074
[TBL] [Abstract][Full Text] [Related]
11. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
[TBL] [Abstract][Full Text] [Related]
12. Phytochemicals and their potential usefulness in inflammatory bowel disease.
Somani SJ; Modi KP; Majumdar AS; Sadarani BN
Phytother Res; 2015 Mar; 29(3):339-50. PubMed ID: 25572840
[TBL] [Abstract][Full Text] [Related]
13. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.
Rivera Rodríguez R; Johnson JJ
Pharmacol Ther; 2023 Aug; 248():108456. PubMed ID: 37247693
[TBL] [Abstract][Full Text] [Related]
14. First-line therapies in inflammatory bowel disease.
Girardin M; Manz M; Manser C; Biedermann L; Wanner R; Frei P; Safroneeva E; Mottet C; Rogler G; Schoepfer AM
Digestion; 2012; 86 Suppl 1():6-10. PubMed ID: 23051720
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
16. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.
Stefanelli T; Malesci A; Repici A; Vetrano S; Danese S
Curr Drug Targets; 2008 May; 9(5):413-8. PubMed ID: 18473770
[TBL] [Abstract][Full Text] [Related]
17. Oral locally active steroids in inflammatory bowel disease.
Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M
J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947
[TBL] [Abstract][Full Text] [Related]
18. Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K; Petersen AM
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
[TBL] [Abstract][Full Text] [Related]
19. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
Alimohammadi N; Koosha F; Rafeian-Kopaei M
Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy of inflammatory bowel disease for the 21st century.
Robinson M
Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
